首页 正文

Mosunetuzumab for the treatment of follicular lymphoma

{{output}}
Introduction: Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma that shows a progressive increase in relapses and refractory in its natural history and a median survival of approximately 18-20 years. The advent of anti... ...